Updates ·
Health notices · Thursday 5 November
3 notices from the agencies today, in plain words, each with the original linked.
FDA approval of COMETRIQ (cabozantinib) for medullary thyroid cancer
FDA · Approval
If you have progressive, metastatic medullary thyroid cancer (MTC), the US Food and Drug Administration has approved COMETRIQ (cabozantinib) as a treatment option.
COMETRIQ is a kinase inhibitor. A kinase inhibitor is a medicine that blocks certain signals in cancer cells that can help them grow.
What this changes for you: it may let your clinician prescribe COMETRIQ for your condition.
FDA class II action for certain cavity-protection toothpaste
FDA · Recall
If you have ARU Toothpaste, Cavity Protection, Cool Mint (9 ingredients) with sodium fluoride 0.243%, you may be affected. The FDA listed a Class II action due to CGMP deviations (manufacturing quality requirements).
The notice applies to ARU Toothpaste distributed US nationwide. It was published on 2026-10-28. No specific next steps were provided in the notice details shown.
CDC updated parenting tips for infants and toddlers
Centers for Disease Control and Prevention (CDC) · Guidance
If you’re raising a child from birth to age 3, the CDC has updated its “Infants & Toddlers: Raising Healthy Children” parent page.
It’s a collection of links covering topics like handwashing, developmental milestones, infant and toddler nutrition, hearing screening, safe diapering, and vaccines for children.